Enhabit, Inc.

$13.80+0.07%(+$0.01)
TickerSpark Score
70/100
Solid
90
Valuation
35
Profitability
70
Growth
56
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EHAB research report →

52-Week Range95% of range
Low $6.47
Current $13.80
High $14.22

Companywww.ehab.com

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

CEO
Barbara Ann Jacobsmeyer
IPO
2022
Employees
10,600
HQ
Dallas, TX, US

Price Chart

+30.43% · this period
$14.09$10.30$6.52May 14Nov 12May 14

Valuation

Market Cap
$706.91M
P/E
-220.80
P/S
0.66
P/B
1.28
EV/EBITDA
20.03
Div Yield
0.00%

Profitability

Gross Margin
47.93%
Op Margin
7.25%
Net Margin
-0.30%
ROE
-0.58%
ROIC
-1.58%

Growth & Income

Revenue
$1.06B · 2.44%
Net Income
$-4,600,000 · 97.06%
EPS
$-0.09 · 97.09%
Op Income
$63.80M
FCF YoY
38.82%

Performance & Tape

52W High
$14.22
52W Low
$6.47
50D MA
$13.76
200D MA
$10.26
Beta
0.96
Avg Volume
1.65M

Get TickerSpark's AI analysis on EHAB

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 15, 26Jacobsmeyer Barbara Annother340,530
May 15, 26Jacobsmeyer Barbara Annother263,237
May 15, 26Jacobsmeyer Barbara Annsell413,614
May 15, 26Jacobsmeyer Barbara Annsell65,964
May 15, 26Jacobsmeyer Barbara Annsell340,530
May 15, 26Black Dylan Csell41,263
May 15, 26Black Dylan Cother49,601
May 15, 26Black Dylan Cother34,413
May 15, 26Black Dylan Cother24,072
May 15, 26Black Dylan Csell24,072

Our EHAB Coverage

We haven't published any research on EHAB yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate EHAB Report →

Similar Companies